-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cm6v+8X1ZPeMbSk2KUbPRzmQtHvijHiyFejk+SCjxsQaZl2ySVXzFZGfBbtM+B8x gRITTmMJ3JhPjql3ythNcw== 0001218815-03-000003.txt : 20031002 0001218815-03-000003.hdr.sgml : 20031002 20031002143930 ACCESSION NUMBER: 0001218815-03-000003 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030930 FILED AS OF DATE: 20031002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONRAD HERBERT J CENTRAL INDEX KEY: 0001218815 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 03923706 MAIL ADDRESS: STREET 1: 134 LOWELL RD CITY: GLEN ROCK STATE: NJ ZIP: 07452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4/A 1 edgar.xml PRIMARY DOCUMENT X0201 4/A2003-09-302003-10-01 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218815 CONRAD HERBERT J 134 LOWELL ROAD GLEN ROCK NJ 07452 1000Common stock, $.01 par value per share2003-09-302003-09-304A04955.05A10547 DOptions to purchase common stock, $.01 par value per share5.052003-09-302003-09-304A050005.05A< value>2004-09-302013-09-30Common stock, $.01 par value per share500072500DThese shares were granted pursuant to the Company's Stock Compensation Plan for Outside Directors, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $2,500, until he is no longer an Outside Director. On September 3 0, 2003, the fair market value of the Common Stock, based on the closing price, was $4.14.These options will become fully vested and immediately exercisable on 9/30/2004.Amended filing due to erroneous stock price of grant./s/ Herbert Conrad2003-10-02 -----END PRIVACY-ENHANCED MESSAGE-----